GREY:CNTTQ - Post by User
Comment by
Druckenmilleron Jan 21, 2019 6:34pm
![](https://assets.stockhouse.com/kentico-cms/0341-00/images/Sprite.svg#id_Post_Views_Icon)
253 Views
Post# 29262008
RE:RE:RE:RE:RE:If this can overcome the nine's
RE:RE:RE:RE:RE:If this can overcome the nine'sThanks, best of luck to you as well. I've been investing in this sector for a long time and if I were an outside company looking to make an acquisition in order to begin developing products... TRST would be top of list for value. If you have a ton of cash to spend like Constellation did than obviously ACB is top notch. However, the Altria deal with CRON has made me think that these big players know that MJ will eventually become commoditized so IP is going to be of what's value in the future not production capability. Those who've done their DD on TRST, know that they have already developed the tech for drinks, candies, topicals etc... I think Apotex is playing a strong role in their product development.
The only risk I see right now is Cannamed selling shares but i think it could have been either to bring their share count below 10% or possibly to raise cash and buy shares in one of the thousands of opportunities the market delt the world in December. At least with TRST it's clear who the major backer for this company was since it's infancy and it's only normal for them to take profits from time to time. Sheryl Sandberg sold half her FB shares by 2014, following her lead wouldn't have been smart.